Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1991-03-29
1993-10-05
Husarik, Nancy S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 54, 536 21, 536 53, 536 553, 536124, A61K 31725, C08B 3710
Patent
active
052505197
ABSTRACT:
A non-anticoagulant (NAC) form of heparin which shows antiproliferative activity with respect to smooth muscle cells is useful in the prevention of restenosis and other conditions benefited by antiproliferative activity with respect to smooth muscle cells. This NAC form of heparin is prepared by deacetylating and then oxidizing heparin/heparan sulfate substantially to completion with periodate followed by reduction of the resulting aldehyde groups under conditions which prevent depolymerization of the heparin.
REFERENCES:
patent: 4816446 (1989-03-01), Feller et al.
patent: 4981955 (1991-01-01), Lopez
patent: 5032679 (1991-07-01), Brandley et al.
patent: 5104860 (1992-04-01), Piani et al.
patent: 5116962 (1992-05-01), Stuber et al.
Mcall's Dictionary of Chemistry Sharp (Ed.) (1981) p. 251.
Nagasawa et al; J. Biochem, 81:989-993 (1977).
Hoover et al; Circ. Res. 47(4):578-583 (1980).
Nagasawa et al; Carb. Res. 111:273-281 (1983).
Shaklee et al; Biochem. J. 217:187-197 (1984).
Oasu et al; Chemical Abstracts 112:120980x (1990).
Austin et al., J. Am. Coll. Cardiol. (1985) 6:369-375.
Guo et al., Anal. Biochem. (1988) 268:54-62.
Clowes et al., Nature (1977) 265:625-626.
Marcum et al., Biology of Proteoglycan, Academic Press (1987) pp. 301-343.
Castellot, Jr., et al., J. Biol. Chem. (1982) 257:11256-11260.
Benitz et al. J. Cell. Physiol. (1966) 127:1-7.
Orlidge et al., Microvascular Res. (1986) 31:41-53.
Benitz et al., The Pulmonary Circulation: Normal and Abnormal, Fishman, A. P., ed., University of Pennsylvania Press, (1988) 30 pages.
Castellot, Jr. et al., J. Cell. Physiol (1984) 120:315-320.
Castellot, Jr., et al, J. Cell. Biol. (1986) 102:1979-1984.
Barzu et al. J. Cell Physiol. (1989) 140:538-548.
Wright et al., J. Biol. Chem. (1989) 264:1534-1542.
Fransson et al., FEBS Letters (1979) 97:119-123.
Casu et al., Arzneim Forch/Drug Res. (1986) 36:637-642.
Fransson et al., Carbohydrate Res. (1980) 80:131-145.
Bjornsson et al., J. Pharmacol. & Exper. Therap. (1988) 245(3):804-808.
Edge et al., Arch. Biochem. & Biophys. (1985) 240(2):560-572.
Conrad H. Edward
Guo Yuchuan
Giotta Gregory J.
Glycomed Incorporated
Husarik Nancy S.
LandOfFree
Non-anticoagulant heparin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-anticoagulant heparin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-anticoagulant heparin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1003887